Fig. 9From: Pan-histone deacetylase inhibitor vorinostat suppresses osteoclastic bone resorption through modulation of RANKL-evoked signaling and ameliorates ovariectomy-induced bone lossProposed schematic diagram for SAHA suppression on RANKL-induced osteoclastogenesis. The high affinity between SAHA and RANKL results in blockade of RANKL-RANK interaction, thereby interfering with RANKL-induced signaling cascades and osteoclastic bone resorption. Additionally, SAHA administration effectively ameliorates ovariectomy-induced bone loss in miceBack to article page